<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Even as the new highly-mutated strain of the coronavirus, named omicron, threatens the fledgling post-pandemic recovery across the globe, biopharma companies are ramping up efforts to help. What Happened: Moderna, Inc. (NASDAQ: MRNA), which was the second biopharma company to get authorization for a COVID-19 vaccine, is confident it will have something on the table shortly to tackle the latest virus threat.
...read full article on Benzinga
